238 related articles for article (PubMed ID: 16938171)
41. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
[TBL] [Abstract][Full Text] [Related]
42. [Determination and significance of serum markers for fibrosis in patients with chronic hepatitis].
Cai W; Zheng M; Weng H; Liu R
Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):448-51. PubMed ID: 11798612
[TBL] [Abstract][Full Text] [Related]
43. Imaging diagnosis of cirrhosis and chronic hepatitis.
Ito K; Mitchell DG
Intervirology; 2004; 47(3-5):134-43. PubMed ID: 15383722
[TBL] [Abstract][Full Text] [Related]
44. Frequency of osteoporosis in patients with cirrhosis due to hepatitis B and hepatitis C: a study of 100 cases.
Javed M; Saeed A; Khan IM; Hameed K; Rehman S; Khattak AK; Ahmad I; Khan SA
J Ayub Med Coll Abbottabad; 2009; 21(3):51-3. PubMed ID: 20929012
[TBL] [Abstract][Full Text] [Related]
45. Diffusion-weighted imaging (DWI) of the spleen in patients with liver cirrhosis and portal hypertension.
Klasen J; Lanzman RS; Wittsack HJ; Kircheis G; Schek J; Quentin M; Antoch G; Häussinger D; Blondin D
Magn Reson Imaging; 2013 Sep; 31(7):1092-6. PubMed ID: 23731536
[TBL] [Abstract][Full Text] [Related]
46. [The relationship between 31P magnetic resonance spectroscopy and the histopathology of livers of chronic viral hepatitis patients].
Wu B; Song B; Zhou XP; Yang Y; Lei XZ; Jiang LL
Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):338-41. PubMed ID: 17524264
[TBL] [Abstract][Full Text] [Related]
47. Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis.
Olmez OF; Gurel S; Yilmaz Y
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):461-5. PubMed ID: 19940783
[TBL] [Abstract][Full Text] [Related]
48. Hepatic ADC value correlates with cirrhotic severity of patients with biliary atresia.
Mo YH; Jaw FS; Ho MC; Wang YC; Peng SS
Eur J Radiol; 2011 Dec; 80(3):e253-7. PubMed ID: 21123015
[TBL] [Abstract][Full Text] [Related]
49. Semi-quantitative assessment of the presence and Child-Pugh class of hepatitis B related cirrhosis by using liver lobe-based dynamic contrast-enhanced MRI.
Zhou L; Wang LY; Zhang XM; Zeng NL; Chen TW; Li R; Huang YC; Tang YL
Clin Radiol; 2016 Dec; 71(12):1289-1295. PubMed ID: 27633724
[TBL] [Abstract][Full Text] [Related]
50. Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation.
Kim KA; Park MS; Kim IS; Kiefer B; Chung WS; Kim MJ; Kim KW
J Magn Reson Imaging; 2012 Aug; 36(2):405-10. PubMed ID: 22392835
[TBL] [Abstract][Full Text] [Related]
51. Quantification of superparamagnetic iron oxide-mediated signal intensity change in patients with liver cirrhosis using T2 and T2* mapping: a preliminary report.
Chung YE; Park MS; Kim MS; Kim E; Park J; Song HT; Choi JY; Kim MJ; Kim KW
J Magn Reson Imaging; 2010 Jun; 31(6):1379-86. PubMed ID: 20512890
[TBL] [Abstract][Full Text] [Related]
52. Comparative study of gallbladder motility in patients with chronic HCV hepatitis and with HCV cirrhosis.
Buzaş C; Chira O; Mocan T; Acalovschi M
Rom J Intern Med; 2011; 49(1):37-44. PubMed ID: 22026251
[TBL] [Abstract][Full Text] [Related]
53. [Application of dynamic contrast-enhanced magnetic resonance imaging in evaluating liver fibrosis].
Li XY; Xiong W; Han LJ; Zhang XL; Qiu SJ; Li SL
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1259-63. PubMed ID: 21764710
[TBL] [Abstract][Full Text] [Related]
54. [Diagnostic values of serum levels of HA, PC III, C IV and LN to the liver fibrosis in children with beta-thalassemia major].
Xu HG; Fang JP; Huang SL; Li HG; Zhong FY; Guo HX; Su H
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):603-6. PubMed ID: 14744384
[TBL] [Abstract][Full Text] [Related]
55. Value of MR diffusion imaging in hepatic fibrosis and its correlations with serum indices.
Hu XR; Cui XN; Hu QT; Chen J
World J Gastroenterol; 2014 Jun; 20(24):7964-70. PubMed ID: 24976733
[TBL] [Abstract][Full Text] [Related]
56. [The relationship between TGFbeta1 and TIMP-1 and its effects on the diagnosis of hepatic fibrosis].
Zhang LF; Tian XX; Wang CF
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):258-60. PubMed ID: 17456311
[TBL] [Abstract][Full Text] [Related]
57. Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage.
Mansour-Ghanaei F; Mehrdad M; Mortazavi S; Joukar F; Khak M; Atrkar-Roushan Z
Ann Hepatol; 2012; 11(5):667-71. PubMed ID: 22947527
[TBL] [Abstract][Full Text] [Related]
58. [Clinical significance of serum differential protein examination in chronic hepatitis B related liver fibrosis].
Li SB; Tong YX; Ding XJ; Lin ZY; Zhang ZE; Li SZ
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):881-5. PubMed ID: 21205470
[TBL] [Abstract][Full Text] [Related]
59. [Pathogenesis of liver fibrosis in patients with chronic hepatitis B].
Shi J; Hao JH; Ren WH; Zhu JR; Wang SY; Xie YB
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):443-5. PubMed ID: 19567024
[TBL] [Abstract][Full Text] [Related]
60. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings.
Cho SG; Kim MY; Kim HJ; Kim YS; Choi W; Shin SH; Hong KC; Kim YB; Lee JH; Suh CH
Radiology; 2001 Dec; 221(3):740-6. PubMed ID: 11719670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
